Higher Medicare Premiums For US Wealthy Proposed

14 July 1997

President Bill Clinton says he will think about agreeing to Republicanplans to raise Medicare premiums for wealthy recipients, an important shift in attempts to reach a compromise with the GOP on balanced-budget legislation.

Speaking at a news conference after the Northern Atlantic Treaty Organization meeting in Madrid, Spain, he said that means testing needs to be fair and workable. Aides noted that he will not accept the Senate plan if it puts the overall budget-cutting legislation in danger.

Opinion polls have found that increased premiums are very popular among the public. Until recently, Pres Clinton has said that they should be considered only as part of a broader attempt to overhaul health care programs. However, Republicans feel that Administration plans to have the Internal Revenue Service run the system, which will charge wealthier Medicare recipients higher premiums, is a "poison pill," as it will make the increased payments look like a tax increase.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight